Thermo Fisher Scientific Inc has a consensus price target of $538.79, established from looking at the 100 latest analyst ratings. The last 3 analyst ratings were released from HSBC, Goldman Sachs, and Evercore ISI Group on April 17, 2024, April 10, 2024, and April 4, 2024. With an average price target of $636.67 between HSBC, Goldman Sachs, and Evercore ISI Group, there's an implied 16.82% upside for Thermo Fisher Scientific Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
04/17/2024 | TMO | Buy Now | Thermo Fisher Scientific | $545.00 | 21.1% | HSBC | Rajesh Kumar | $630 → $660 | Maintains | Buy | Get Alert |
04/10/2024 | TMO | Buy Now | Thermo Fisher Scientific | $545.00 | 17.43% | Goldman Sachs | Matthew Sykes | $550 → $640 | Maintains | Buy | Get Alert |
04/04/2024 | TMO | Buy Now | Thermo Fisher Scientific | $545.00 | 11.93% | Evercore ISI Group | Vijay Kumar | $575 → $610 | Maintains | Outperform | Get Alert |
03/18/2024 | TMO | Buy Now | Thermo Fisher Scientific | $545.00 | 13.76% | Citigroup | Patrick Donnelly | → $620 | Reinstates | → Neutral | Get Alert |
02/01/2024 | TMO | Buy Now | Thermo Fisher Scientific | $545.00 | 17.8% | RBC Capital | Conor McNamara | $592 → $642 | Maintains | Outperform | Get Alert |
02/01/2024 | TMO | Buy Now | Thermo Fisher Scientific | $545.00 | 11.01% | Raymond James | Andrew Cooper | $515 → $605 | Maintains | Outperform | Get Alert |
01/24/2024 | TMO | Buy Now | Thermo Fisher Scientific | $545.00 | 1.83% | Barclays | Luke Sergott | $475 → $555 | Downgrade | Overweight → Equal-Weight | Get Alert |
01/08/2024 | TMO | Buy Now | Thermo Fisher Scientific | $545.00 | — | Bernstein | Eve Burstein | — | Downgrade | Outperform → Market Perform | Get Alert |
12/18/2023 | TMO | Buy Now | Thermo Fisher Scientific | $545.00 | 11.93% | HSBC | Rajesh Kumar | → $610 | Initiates | → Buy | Get Alert |
12/14/2023 | TMO | Buy Now | Thermo Fisher Scientific | $545.00 | 22.94% | Baird | Catherine Schulte | → $670 | Maintains | Outperform | Get Alert |
12/13/2023 | TMO | Buy Now | Thermo Fisher Scientific | $545.00 | — | Wolfe Research | Doug Schenkel | — | Initiates | → Outperform | Get Alert |
12/11/2023 | TMO | Buy Now | Thermo Fisher Scientific | $545.00 | 5.5% | Citigroup | Patrick Donnelly | $530 → $575 | Maintains | Buy | Get Alert |
11/06/2023 | TMO | Buy Now | Thermo Fisher Scientific | $545.00 | 0.92% | Argus Research | David Toung | $540 → $550 | Maintains | Buy | Get Alert |
10/26/2023 | TMO | Buy Now | Thermo Fisher Scientific | $545.00 | -3.85% | Baird | Catherine Schulte | $589 → $524 | Maintains | Outperform | Get Alert |
10/26/2023 | TMO | Buy Now | Thermo Fisher Scientific | $545.00 | -12.84% | Barclays | Luke Sergott | $585 → $475 | Maintains | Overweight | Get Alert |
10/26/2023 | TMO | Buy Now | Thermo Fisher Scientific | $545.00 | -2.75% | Stifel | Daniel Arias | $660 → $530 | Maintains | Buy | Get Alert |
10/26/2023 | TMO | Buy Now | Thermo Fisher Scientific | $545.00 | 6.24% | RBC Capital | Conor McNamara | $657 → $579 | Maintains | Outperform | Get Alert |
10/26/2023 | TMO | Buy Now | Thermo Fisher Scientific | $545.00 | -2.75% | Citigroup | Patrick Donnelly | $625 → $530 | Maintains | Buy | Get Alert |
10/26/2023 | TMO | Buy Now | Thermo Fisher Scientific | $545.00 | -5.5% | Raymond James | Andrew Cooper | $580 → $515 | Maintains | Outperform | Get Alert |
The latest price target for Thermo Fisher Scientific (NYSE: TMO) was reported by HSBC on April 17, 2024. The analyst firm set a price target for $660.00 expecting TMO to rise to within 12 months (a possible 21.10% upside). 63 analyst firms have reported ratings in the last year.
The latest analyst rating for Thermo Fisher Scientific (NYSE: TMO) was provided by HSBC, and Thermo Fisher Scientific maintained their buy rating.
The last upgrade for Thermo Fisher Scientific Inc happened on July 13, 2023 when Credit Suisse raised their price target to $620. Credit Suisse previously had a neutral for Thermo Fisher Scientific Inc.
The last downgrade for Thermo Fisher Scientific Inc happened on January 24, 2024 when Barclays changed their price target from $475 to $555 for Thermo Fisher Scientific Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Thermo Fisher Scientific, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Thermo Fisher Scientific was filed on April 17, 2024 so you should expect the next rating to be made available sometime around April 17, 2025.
While ratings are subjective and will change, the latest Thermo Fisher Scientific (TMO) rating was a maintained with a price target of $630.00 to $660.00. The current price Thermo Fisher Scientific (TMO) is trading at is $545.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.